Company intelligence / Profile preview

Yueda Diaverum Renal Care

Malmö, Sweden

Ownership: Private
Employees: ~13500
Development stage: Other

Overview

Diaverum operates 450 clinics across 24 countries, treating approximately 42,000-43,000 patients with over 4 million treatments annually. The company implements value-based renal care models that have demonstrably improved medical outcomes while reducing total cost of care, as evidenced by independent review of their Portuguese operations by the London School of Economics.

Therapeutic areas: Nephrology
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Yueda Group (China health investment and operation)Taipei Medical UniversityPortuguese Ministry of Health (dialysis clinic operations)

Beyond the preview

Go deeper on Yueda Diaverum Renal Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yueda Diaverum Renal Care.

Explore the full profile